Skip to main content
. Author manuscript; available in PMC: 2018 Dec 11.
Published in final edited form as: Biomacromolecules. 2017 Nov 14;18(12):4163–4170. doi: 10.1021/acs.biomac.7b01220

Fig. 2.

Fig. 2

Encapsulation stability of the nanogel with different cross-link degrees in serum: (A, B) non-crosslinked nanoassembly, (C, D) nanogel with 20% cross-link density, (E, F) nanogel with 60% cross-link density, (G, H) nanogel with 100% cross-link density. Condition: mixture of 0.05 mL of the nanogel (2 mg/mL) and 0.95 mL 100% serum.